SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
India
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Albert David Ltd.

Main Activities: Chemical Manufacturing - Health and Personal Care Stores

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Albert David Ltd.

Legal Address
15, Chittaranjan Avenue, 2nd Floor; Kolkata; West Bengal; 700072
Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
ISIN CODE : INE155C01010
Financial Auditors: G Basu & Co (2012)
Incorporation Date: November 16, 1938

Tel: 033- 22129700 22129637 22129592

Company Description

Albert David Limited operates as a pharmaceutical company primarily in India. The company manufactures pharmaceutical formulations, infusion solutions, herbal products, bulk drugs, and disposable syringes and needles. It primarily focuses on analgesics, anti-inflammatory, anti pyretics, anti-bacterials, anti-ulcerants, dermatologicals, anxiolytics, parenterals, herbal remedies, nutrition/vitamins, haematinics, placental extracts, cough preparations, anthelmintics, and haemostatics. The company is
More

Company Analysis

According to the Individual - Audited financial statement for the Year of 2012, total net operating revenues increased with 4.98%, from INR 221.07 tens of millions to INR 232.08 tens of millions. Operating result decreased from INR 27.03 tens of millions to INR 23.49 tens of millions which means -13.10% change. The results of the period decreased -29.03% reaching INR 7.53 tens of millions at the end of the period against INR 10.61 tens of millions last year. Return on equity (Net income/Total equity) went from 14.96% to 9.97%, the Return On Asset (Net income / Total Asset) went from 8.51% to 3.71% and the Net Profit Margin (Net Income/Net Sales) went from 4.80% to 3.24% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 268.44% compared to 175.76% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.20 to 1.46 when compared to the previous year.

Key Executives

AK Kothari Chairman & Managing Director
AK Kothari Chairman & Managing Director
K P Mundhra Executive Director
AV Iyengar Non Executive & Independent Director
H Kampani Non Executive & Independent Director
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Shareholders Equity

5

5

* All the accounts are in INR.
Income Statement

Total Operating Revenue

145

66

Operational Profit (Loss)

12

3

Net Profit (Loss)

7

1

* All the accounts are in INR.
Ratios
Profitability Ratios

Return on Equity (ROE)

128.37%

25.74%

Annualised Return on Equity (ROE)

256.74%

102.96%

Return on Sales (ROS)

100.47%

100.29%